The Relation of Serum Bilirubin Level with the Severity and Complexity of Coronary Artery Disease and Long-term Outcomes in the Patients Undergoing Primary Percutaneous Coronary Intervention

سال انتشار: 1395
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 62

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JIML-4-1_006

تاریخ نمایه سازی: 14 مرداد 1402

چکیده مقاله:

Background and Aims: Bilirubin has been considered an antioxidant that protects against atherosclerosis. The aim of this study was to evaluate the relationship of serum bilirubin level with the severity and complexity of coronary artery disease (CAD) and long-term outcome in the patients undergoing primary percutaneous coronary intervention (PCI). Materials and Methods: This prospective cohort study was performed on ۱۳۶ patients with STEMI undergoing PCI in Heshmat Hospital, Rasht, Iran during ۲ years. The complexity was calculated by using dedicated software of the syntax score and the severity of CAD was determined based on the number of vessel involvement. Also, long-term outcomes were evaluated by major adverse cardiac events (MACE ) after one year. Results: The mean total bilirubin level was ۰.۹۵ ± ۰.۶۹ mg/dl; ۶۰.۳% of the patients were in the low range of syntax score (۰-۲۲) and ۳۸.۲ % had two vessels involved. In examining the relationship between serum bilirubin level with the severity and complexity of CAD and MACE, There was no statistically significant association (p>۰.۰۵); but, the majority of the patients with high bilirubin levels had a lower number of vessels involved and the complexity of the vessels; Also, MACE was observed in the patients with low bilirubin levels. Conclusions: According to the results, attention to serum bilirubin level could be important in CAD and the protective effect of bilirubin can be used for new therapeutic decisions. Further studies on a larger sample of patients have been recommended to confirm and complete these findings.

کلیدواژه ها:

نویسندگان

Arsalan Salari

Department of Cardiology, Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Fatemeh Moaddab

Department of Nursing, Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Mahsa Pourabdollah Tootkaboni

Department of Cardiology, Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Maryam Shakiba

Department of Epidemiology, Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

Mohadeseh Poursadeghi

Department of Nursing, Guilan Interventional Cardiovascular Research Center, Heshmat Hospital, Guilan University of Medical Sciences, Rasht, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, ...
  • . Rahbar S, Ahmadiasl N. Effect of Long Term Regular ...
  • . Karajibani M, Montazerifar F, Hashemi M, Bolouri A, Dikshit ...
  • . Steghamati A, Zarban A, Doosti M. Evaluation of antioxidant ...
  • . Nabatchian F, Einollahi N, Boroomand MA, Abbasi S. Can ...
  • . Lingenhel A, Kollerits B, Schwaiger JP, Hunt SC, Gress ...
  • . Stocker R, Glazer AN, Ames BN. Antioxidant activity of ...
  • . Gullu H, Erdogan D, Tok D, Topcu S, Caliskan ...
  • . Hopkins PN, Wu LL, Hunt SC, James BC, Vincent ...
  • . Han SS, Na KY, Chae DW, Kim YS, Kim ...
  • . Chin HJ, Song YR, Kim HS, Park M, Yoon ...
  • . Giral P, Ratziu V, Couvert P, Carrie A, Kontush ...
  • . Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. ...
  • . Berliner JA, Navab M, Fogelman AM. Atherosclerosis: basic mechanisms. ...
  • . Ghem C, Sarmento-Leite RE, de Quadros AS, Rossetto S, ...
  • . Neuzil J, Stocker R. Free and albumin-bound bilirubin are ...
  • . Mayer M. Association of serum bilirubin concentration with risk ...
  • . Nakayama M, Takahashi K, Komaru T. Increased expression of ...
  • . Stocker R. Antioxidant activities of bile pigments. Antioxidants and ...
  • . Rigato I, Ostrow JD, Tiribelli C. Bilirubin and the ...
  • . Braunwald E, Zipes DP, Libby P, Bonow R. Braunwald's ...
  • . Einollahi N, Boromand MA, Nabatchian F, Abbasi S. The ...
  • . Taban Sadeghi MR, Golmohamadi A, Parvizi R, Kezerlou Aghdam ...
  • . Erdogan T, Cicek Y, Kocaman SA. Increased serum bilirubin ...
  • . Sahin O, Akpek M, Karadavut S, Cosgun MS, Savas ...
  • . Turfan M, Duran M, Poyraz F, Yayla C, Akboga ...
  • . Gul M, Uyarel H, Ergelen M, Akgul O, Karaca ...
  • . Baumann S, Huseynov A, Koepp J, Jabbour C, Behnes ...
  • نمایش کامل مراجع